Diabetic population were reported more likely to suffer carriage and infection with Staphylococcus aureus (S. aureus) and methicillinresistant Staphylococcus aureus (MRSA) than non-diabetic population. We aim to elucidate the prevalence and characteristics of S. aureus and MRSA nasal carriage among diabetic population in the United States National Health and Nutrition Examination Survey, 2001Survey, -2004. Univariate analyses were conducted using Chi-square test, Fisher's exact probability test or student t test, as appropriate. Multivariate analysis using logistic regression was conducted to assess the association between influencing factors and S. aureus and MRSA nasal carriage. 1010 diabetic participants were included in the study. The prevalence of S. aureus and MRSA nasal carriage were 28.32% and 1.09%, respectively. After the logistic regression, ever had a painful sensation or tingling in hands or feet past three months (Odds Ratio [OR] = 0.359, 95% Confidence Interval [CI], 0.146-0.882) was significant among S. aureus nasal carriage and gender (OR = 3.410, 95% CI, 1.091-10.653) was significant among MRSA nasal carriage. The proportions of staphylococcal enterotoxin (SE) A, SEB, SEC, SED, Toxic-shock syndrome toxin-1, and Panton Valentine Leukocidin toxin among S. aureus strains were 18.75%, 3.13%, 12.50%, 15.63%, 28.13%, and 9.38%, respectively. 63.63% of MRSA strains were community-acquired, 27.27% were hospital-acquired, and 9.09% were non-typeable. Diabetic patients might be more likely to carry S. aureus and MRSA in the United States. Improving hand hygiene compliance, reducing antibiotic overuse, screening for carriers, and decolonization are recommended to reduce the spread of S. aureus and MRSA, especially in community. 
Introduction
Staphylococcus aureus (S. aureus) is a common pathogen and can cause different kinds of infection in both hospitals and communities (Knox et al., 2015; Samanta et al., 2015) . Several parts of human body can carry S. aureus and the nasal cavity is the main part. It was reported that S. aureus nasal carriage can increase the possibility of infection (Wertheim et al., 2005) . Methicillin-resistant Staphylococcus aureus (MRSA) was first discovered in 1961 and then widely spread around the world (Chen et al., 2012; Hernandez-Porto et al., 2015) . In the United States, the proportion of methicillin resistance in S. aureus strains approached almost 60% in 2003, with an average resistance rate of approximately 50% over the period from 1998 to 2002 (NNIS, 2004) . In Europe, the proportion of methi cillin resistance in S. aureus strains isolated from infected patients increased from 21% in 2002 21% in to 23% in 2005 21% in and then decreased to 19% in 2008 21% in . Between 2002 21% in and 2005 , the annual increase was 7.6%, followed by an average annual decrease of 4.8% (de Kraker et al., 2013) .
MRSA can increase the mortality rate, prolong hospitalization and aggravate the economic burden (Gastmeier et al., 2012; Lodise and McKinnon, 2005) . MRSA infection, hepatitis B and Acquired Immune Deficiency Syndrome has currently become three global infectious diseases.
Diabetes is a common chronic disease. With the development of social economy, the improvement of living standard and the aging of population, the number of diabetic population is increasing worldwide. The International Diabetes Federation Annual Report in 2014 showed that 387 million people were estimated to be living with diabetes, an alarming number that is set to rise to 592 million within the next twenty years. A further 316 million with impaired glucose tolerance are at high risk from the disease, with projections indicating that over one billion people will be living with or at high risk of diabetes in 2035 (IDF, 2014) . Due to poor long-term blood glucose control or various complications, diabetic population is prone to suffer S. aureus or MRSA infection, which can cause death to a certain extent. Several studies reported that diabetes can increase S. aureus and MRSA carriage and infection (Chen and Pass, 2013; Daeschlein et al., 2015) . In other words, diabetic population was more likely to suffer carriage and even infection with MRSA than non-diabetic population.
There were a few studies focusing on S. aureus and MRSA nasal carriage among diabetic population and the conclusions were different. A Turkey study reported that the rates of S. aureus and MRSA nasal carriage among diabetic outpatient population were 41.9% (127/304) and 0.87% (30/304), respectively (Kutlu et al., 2012) . An Indian study reported that the S. aureus nasal carriage rate among hospitalized diabetic patients was 56.6% (34/60) (Ahluwalia et al., 2000) . A Chinese study reported that the rates of S. aureus and MRSA nasal carriage among hospitalized diabetic patients were 20.5% (41/200) and 0.50% (1/200), respectively (Junhua et al., 2005) . These studies, however, mainly focused on the prevalence and risk factors of S. aureus and MRSA nasal carriage among diabetic population, which were not comprehensive. Therefore, the objective of this current study was to elucidate the prevalence, influencing factors, antibiotic resistance, toxin, and molecular characteristics of S. aureus and MRSA nasal carriage among diabetic population who participated in the United States National Health and Nutrition Examination Survey (NHANES), [2001] [2002] [2003] [2004] .
Experimental

Materials and Methods
Study design and population. The continuous NHANES is a large, annual, cross-sectional survey that is designed to evaluate the nutrition and health status of the US population. The surveys were approved by the National Center for Health Statistics Research Ethics Review Board. Data releases are available in two-year increments. The S. aureus and MRSA nasal carriage data were only collected from this NHANES 2001 NHANES -2004 dataset, so we used these data for analyzing. All participants provided written informed consent and the research ethics boards of the National Center for Health Statistics approved all protocols. More details regarding the informed consent of subjects, survey design, data collection, data procedures and laboratory assessment can be found elsewhere (CDC). Those who were tested the assessment of S. aureus and were self-reported diabetes were included in the current study.
Assessment of prevalence of S. aureus and MRSA. Assessment of S. aureus was conducted for the entire sample, thus, all participants aged one year or older were tested. Specimens collected from the nares were plated on mannitol salt agar, a selective medium for the isolation of S. aureus. After overnight cultures, specimens were used to perform Staphaurex and tube coagulase test. Staphaurex-positive and tube coagulasepositive isolates were identified as S. aureus and saved for further testing. S. aureus isolates were screened for methicillin resistance by the disk diffusion method of the National Clinical and Laboratory Standards Institute.
Diagnosed diabetes status. Diagnosed diabetes was identified in participants who answered "yes" to the self-reported question, "Have you ever been told by a doctor or health professional that you had diabetes?" and/or who used diabetes medication (i.e. oral hypoglycemic agents and/or insulin).
Potential influencing factors. Several variables were investigated as potential characteristics indicative of nasal carriage of S. aureus and MRSA among diabetic population. These factors included the selfreported diabetic characteristics variables, self-reported demographic variables, body measures variables, selfreported current health variables, self-reported medical conditions variables, self-reported alcohol use variables, self-reported drug use variables, self-reported physical activity variables, self-reported prescription medications variables, and self-reported exposure to cigarette smoke (operationalized as either being a smoker or living in a house with a current smoker). Given the limited population carriage of MRSA, we investigated a limited number of characteristics based on whether the sample size was large enough to make a reliable population estimate.
Assessment of antibiotic resistance of S. aureus and MRSA. Antibiotic resistance of S. aureus and MRSA was through antibiotic susceptibility testing by broth microdilution using Clinical and Laboratory Standards Institute reference methods. We calculated the resistance of 18 common antibiotics including tetracycline, clindamycin, erythromycin, penicillin, imipenem, vancomycin, cefazolin, oxacillin, gentamicin, ciprofloxacin, levofloxacin, rifampin, amoxicillin, chloramphenicol, doxycycline, daptomycin, quinupristin-dalfopristin, and linezolid . Moreover, we calculated multidrug resistance (MDR), which was defined as resistant to three or more antibiotics with different mechanisms of action 441 (note that these strains are already resistant to all betalactam antibiotics).
Assessment of toxin characteristics and molecular characteristics of S. aureus and MRSA. Strain typing by singleplex polymerase chain reaction (PCR) for detection of staphylococcal enterotoxins (SEs), toxic shock syndrome toxin-1 (TSST-1), Panton-Valentine Leukocidin (PVL) toxin, and staphylococcal cassette chromosome mec (SCCmec) type. SCCmec type is an important classification of MRSA that can be used to trace the source of the bacteria. According to some international reports, SCCmec I-III are designated as hospital-acquired (HA), SCCmec IV and V are designated as community-acquired (CA), and others are designated as non-typeable (NT) strains (Ito et al., 2003; Okuma et al., 2002) . Although there have been studies (Freitas et al., 2010 ) that reported possible misclassification errors for this typing, we still referenced it because there are no other accurate classifications.
Statistical analysis. Means and standard errors were calculated for continuous variables, and frequencies (percentages) were calculated for categorical variables. Univariate analyses were conducted using Chisquare test, Fisher's exact probability test or student t test, as appropriate. Multivariate analysis using logistic regression was conducted to assess the association between influencing factors and S. aureus and MRSA nasal carriage. We also conducted a logistic regression analysis of all variables with a P value of < 0.10 and then removed variables with a P value of ≥ 0.10. All statistical analyses were two-sided. All the statistical analyses were performed using Stata 13.1 (College Station, Texas, USA).
Results
Prevalence of S. aureus and MRSA nasal carriage.
According to the inclusion criteria of study population there were 1010 diabetic population included in the current study. The prevalence of S. aureus, MRSA, and methicillin-sensitive Staphylococcus aureus (MSSA) nasal carriage were 28.32% (286/1010), 1.09% (11/1010), and 27.23% (275/1010) respectively.
Influencing factors of S. aureus and MRSA nasal carriage. We found that military status (P = 0.027), marital status (P = 0.001), ever still had a liver condition (P = 0.033), ever had cancer or malignancy (P = 0.038), ever blood relatives had diabetes (P = 0.030), ever taken antibiotics past month (P = 0.017), ever taken diabetic pills to lower blood sugar (P = 0.040), ever had numbness (P = 0.071), ever had a painful sensation or tingling in hands or feet past three months (P = 0.026), number of days used street drugs over past year (P < 0.001), and ever had five or more drinks every day (P = 0.043) were associated with S. aureus nasal carriage among diabetic population in this current study.
Gender (P = 0.068), number of alcoholic drinks per day over past 12 months (P = 0.048), number of days had five or more drinks past 12 months (P = 0.036), ever had vigorous activity past 30 days (P = 0.070), ever had moderate activity past 30 days (P = 0.081), frequency of playing or exercising hard every week (P = 0.050), and number of hours using TV, video or computer every day (P = 0.002) were associated with MRSA nasal carriage among diabetic population in this current study. More details can be found in Table I and Supplementary materials.
To account for potential confounding among the influencing factors, we further analyzed the relationship between the potential predictors with a logistic regression model. This model showed that when controlling for the effect of the other influencing factors, the relationships found in the univariate analyses changed. Ever had a painful sensation or tingling in hands or feet past three months was still associated with S. aureus nasal carriage among diabetic population in this logistic regression model. Having a painful sensation or tingling in hands or feet past three months was a protective factor. Having a painful sensation or tingling in hands or feet past three months among diabetic population were 0.359 times (95% Confidence Interval [CI], 0.146-0.882) less likely than those not having a painful sensation or tingling in hands or feet past three months to carry S. aureus. Gender was still associated with MRSA nasal carriage among diabetic population in this logistic regression model. Female was a risk factor. Female diabetic population was 3.410 times (95% CI, 1.091-10.653) more likely than male diabetic population to carry MRSA. More details can be found in Table II and Table III .
Antibiotic resistance of S. aureus nasal carriage. Among the proportions of antibiotic resistance in MRSA strains, penicillin (100.00%), imipenem (100.00%), cefazolin (100.00%), oxacillin (100.00%), and amoxicillin (100.00%) were the highest, followed by erythromycin (72.73%), tetracycline (27.27%), levofloxacin (27.27%), clindamycin (18.18%), chloramphenicol (11.11%), vancomycin (0.00%), gentamicin (0.00%), ciprofloxacin (0.00%), rifampin (0.00%), doxycycline (0.00%), daptomycin (0.00%), quinupristin-dalfopristin (0.00%), and linezolid (0.00%). Specially, there was no MRSA strain resistant to vancomycin, gentamicin, ciprofloxacin, rifampin, doxycycline, daptomycin, quinupristin-dalfopristin, and linezolid. Among the proportions of antibiotic resistance in MSSA strains, erythromycin (90.48%) and penicillin (90.48%) were the highest, followed by tetracycline (0.00%), vancomycin (0.00%), clindamycin (0.00%), imipenem (0.00%), cefazolin (0.00%), oxacillin (0.00%), gentamicin (0.00%), ciprofloxacin (0.00%), levofloxacin (0.00%), rifampin (0.00%), amoxicillin (0.00%), chloramphenicol (0.00%), doxycycline (0.00%), daptomycin (0.00%), quinupristin-dalfopristin (0.00%), and linezolid (0.00%). Specially, there was no MSSA strain resistant to tetracycline, vancomycin, clindamycin, imipenem, cefazolin, oxacillin, gentamicin, ciprofloxacin, levofloxacin, rifampin, amoxicillin, chloramphenicol, doxycycline, daptomycin, quinupristindalfopristin, and linezolid. Moreover, there was no MDR S. aureus strain. There were significantly differences between MRSA and MSSA strains in tetracycline (P = 0.012), imipenem (P = 0.007), cefazolin (P = 0.007), oxacillin (P < 0.001), levofloxacin (P = 0.007), and amoxicillin (P = 0.070). More details can be found in Table IV . Toxin characteristics of S. aureus nasal carriage. No MRSA strain was positive to SEA while 28.57% of MSSA strains were positive to it. No MRSA strain was positive to SEB while 4.76% of MSSA strains were positive to it. 18.18% of MRSA strains were positive to SEC while 9.52% of MSSA strains were positive to it. 36.36% of MRSA strains were positive to SED while 4.76% of MSSA strains were positive to it. Both MRSA and MSSA strains were not positive to SEE or SEH. 9.09% of MRSA strains were positive to STTS-1 while 38.10% of MSSA strains were positive to it. With regard to PVL, 18.18% of MRSA strains were positive to it while no MSSA strain was positive to it. There were significantly differences between MRSA and MSSA strains in SEA (P = 0.049), SED (P = 0.019), TSST-1 (P = 0.083), and PVL (P = 0.044). More details can be found in Table V . Molecular characteristics of MRSA nasal carriage. With regard to outcomes of SCCmec type among 11 MRSA strains, IV (63.64%) was the highest, followed by II (27.27), NT (9.09), I (0.00), III (0.00), and V (0.00). 63.64% of MRSA strains were CA, 27.27% were HA, and 9.09% were NT.
Discussion
This current study comprehensively elucidate the prevalence, influencing factors, antibiotic resistance, toxin and molecular characteristics of S. aureus and (Kutlu et al., 2012) , that of long-term hemodialysis type 2 diabetes patients in Saudi Arabia (72.41%, 42/58) (Saxena et al., 2002) , that of hospitalized diabetic patients in India (56.67%, 34/60) (Ahluwalia et al., 2000) , and that of communitybased diabetes patients in Australia (39.09%, 258/660) (Hart et al., 2015) , but was higher than that of hospitalized diabetic patients (20.50%, 41/200) (Junhua et al., 2005) and community-based type 2 diabetes patients in China (10.31%, 43/417) (Yan et al., 2015) . The prevalence of MRSA (1.09%, 11/1010) nasal carriage among S. aureus diabetic population in this current study was lower than community-based type 2 diabetes patients in China (5.28%, 22/417) (Yan et al., 2015) , that of diabetic outpatient population in Turkey (9.87%, 30/304) (Kutlu et al., 2012) , and that of long-term hemodialysis type 2 diabetes patients in Saudi Arabia (18.97%, 11/58) (Saxena et al., 2002) , but was higher than hospitalized diabetic patients in China (0.50%, 1/200) (Junhua et al., 2005) , that of community-based diabetes patients in Australia (1.21%, 8/660) (Hart et al., 2015) , and that of type 1 diabetes pediatric outpatients in Turkey (in 2005, 0.99%, 1/101; in 2013, 0.75%, 1/134) (KaradagOncel et al., 2015) . From the above statistics, we can know that the prevalence of S. aureus and MRSA nasal carriage among diabetic population were different in different countries and regions, and diabetic population might be more likely to carry S. aureus and MRSA in United States. 445
There were studies reported that the main influencing factors of S. aureus and MRSA nasal carriage were gender (Geofrey et al., 2015; Soltani et al., 2014; Yan et al., 2015) , age (Geofrey et al., 2015; Huifen et al., 2015; Soltani et al., 2014) , weight (Campbell et al., 2015) , history of hospitalization (Huifen et al., 2015; Karanika et al., 2015) , history of invasive operation (Karanika et al., 2015; Qiongxiang, 2014) , conditions of antibiotic using (Qiongxiang, 2014; Soltani et al., 2014) , chronic diseases (Campbell et al., 2015; Chen and Pass, 2013; Daeschlein et al., 2015; Geofrey et al., 2015; Huifen et al., 2015; Karanika et al., 2015) , history of infection (Chen and Pass, 2013; Daeschlein et al., 2015) and so on. After performing a logistic regression, ever had a painful sensation or tingling in hands or feet past three months was still associated with S. aureus nasal carriage among diabetic population in this current study. Having a painful sensation or tingling in hands or feet past three months was a protective factor, which might be resulted from more likely of this population to notice the hygiene of their hands or feet. We found that having a painful sensation or tingling in hands or feet past three months among diabetic population was 0.359 times less likely than those not having a painful sensation or tingling in hands or feet past three months to carry S. aureus. With regard to MRSA nasal carriage among diabetic population in this current study, gender was still associated with it in this logistic regression model. Female was a risk factor, which might be resulted from their weaker immune system. Female diabetic population was 3.410 times more likely than male diabetic population to carry MRSA, which was consistent to a Chinese study (Yan et al., 2015) and a Tanzanian study (Soltani et al., 2014) . Therefore, female diabetic population should be paid more attention to perform surveillance of S. aureus and MRSA so as to avoid carriage and/or infection. We found that both MRSA and MSSA strains in this current study were highly resistant to erythromycin and penicillin, which was similar to several studies (Geofrey et al., 2015; Junhua et al., 2005; Kejela and Bacha, 2013; Morgenstern et al., 2016) and this might be resulted from the extensive use of these antibiotics in medical institutions. But both MRSA and MSSA strains were 100% sensitive to vancomycin, gentamicin, ciprofloxacin, rifampin, doxycycline, daptomycin, quinupristindalfopristin and linezolid, which was similar to several studies (Junhua et al., 2005; Morgenstern et al., 2016) , and it could indicate that these antibiotics can be used to treat S. aureus infection in clinical medication. The propotions of resistance to tetracycline (P = 0.012), imipenem (P = 0.007), cefazolin (P = 0.007), oxacillin (P < 0.001), levofloxacin (P = 0.007), and amoxicillin (P = 0.070) among MRSA strains were significantly higher than MSSA strains. This could indicate that the antibiotic resistance of MRSA strains was more severe than MSSA strains and should be emphasized by healthcare workers. It suggested that healthcare workers should rationally utilize antibiotics, prevent antibiotic abuse and long-term use, and can use antibiotic combination or rotation to avoid reducing sensitivity of S. aureus and MRSA to antibiotics.
The pathogenesis of S. aureus infections depends on the production of surface proteins that mediate bacterial adherence to host tissues, secretion of a series of extracellular toxins, and enzymes that destruct host cells and tissues, avoidance of, or incapacitating, the host immune defense, and growth and spread of bacteria in host cells (Lowy, 1998) . Toxins are proteins secreted by S. aureus into the extracellular matrix during the post-exponential and early stationary phases. These proteins are usually involved in tissue penetration and enable the bacteria to invade its host. They are also cytolytic and help bacterial growth by acquiring essential nutrients such as iron from lysed-cells (Kong et al., 2016) . The SEs genes are super antigens which trigger T-cell activation and proliferation, and their mode of action probably includes activation of cytokine release and cell death via apoptosis and potentially lethal toxic shock syndrome (Lin et al., 2010) . In this current study, 18.18% and 36.36% of MRSA strains were positive to SEC and SED, respectively. 28.57%, 4.76%, 9.52%, and 4.76% of MSSA strains were positive to SEA, SEB, SEC, and SED, respectively. Because SEs can cause vomiting and diarrhea and the toxins are one of the most common causes of food-borne diseases (Kong et al., 2016) , we should pay more attention to those who were positive to them. It has been reported that TSST-1 will stimulate the release of chemokines, such as IL-8 and MIP-3α, IL-2, and TNFα (Otto, 2014) . Activation of immune cells will enhance inflammation and cause mucosal cell barrier disruption, allowing further interaction of the toxin with T-cells and macrophages, leading towards toxic shock syndrome (Larkin et al., 1982) . MSSA (38.10%) strains were more likely than MRSA (9.09%) strains to be positive to TSST-1 (χ 2 = 3.004, P = 0.083), which meant that those who carried MSSA should be paid more attention. PVL has been reported to be associated with CA-MRSA infections (Otto, 2010) , which was consistent with this current study. 28.57% (2/7) of CA-MRSA strains in this current study were positive to it. 18.18% of MRSA strains were positive to PVL, which was higher than health care personnel in Egypt (2.24%, 5/223) (Hefzy et al., 2016) and patients in Indonesia (6.56%, 17/259) (Santosaningsih et al., 2016) , which might be resulted from poor hand hygiene compliance and non-judicious use of antibiotics.
Among 11 MRSA strains, seven (63.63%) were CA, three (27.27%) were HA, and one (9.09%) was NT, which could indicate that the majority of MRSA strains in this current study were from community and relevant departments should pay attention to strengthen the surveillance and disinfection in community.
Overall, there were several limitations in this current study. Firstly, we did not take the environmental characteristics into consideration due to the complex data due to limited financial support. Secondly, we did not follow up the outcome of the included population due to the limited data, which can be studied in the future. Thirdly, there are limited data on the antibiotic resistance, toxin, and molecular characteristics of S. aureus and MRSA, which might lead to some kind of errors.
Conclusions
Diabetic population might be more likely to carry S. aureus and MRSA in United States. Having a painful sensation or tingling in hands or feet past three months might be a protective factor. Female might be a risk factor and female diabetic population should be paid more attention to perform surveillance of S. aureus and MRSA so as to avoid carriage and/or infection. The antibiotic resistance of MRSA strains was more severe than that of MSSA strains and should be emphasized by health-care workers. The proportions of toxins in S. aureus were high and those who detected positive should be paid more attention. Therefore, improving compliance, reducing antibiotic overuse, screening for carriers, and decolonization are recommended strategies for reducing the spread of S. aureus and MRSA. The majority of MRSA strains in this current study were from community and relevant departments should pay greater attention to strengthen the surveillance of S. aureus and MRSA and disinfection measures in community.
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